Co-Authors
This is a "connection" page, showing publications co-authored by Matthew Frieman and Christopher Coleman.
Connection Strength
7.148
-
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection. Vaccine. 2017 03 14; 35(12):1586-1589.
Score: 0.706
-
CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome. J Virol. 2017 Jan 01; 91(1).
Score: 0.696
-
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion. J Virol. 2016 10 01; 90(19):8924-33.
Score: 0.684
-
Growth and Quantification of MERS-CoV Infection. Curr Protoc Microbiol. 2015 May 01; 37:15E.2.1-9.
Score: 0.622
-
Treating MERS-CoV during an outbreak. Lancet Infect Dis. 2014 Nov; 14(11):1030-1031.
Score: 0.597
-
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine. 2014 May 30; 32(26):3169-3174.
Score: 0.578
-
Coronaviruses: important emerging human pathogens. J Virol. 2014 May; 88(10):5209-12.
Score: 0.574
-
Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus. J Gen Virol. 2014 Feb; 95(Pt 2):408-412.
Score: 0.561
-
Emergence of the Middle East respiratory syndrome coronavirus. PLoS Pathog. 2013; 9(9):e1003595.
Score: 0.555
-
Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo. J Virol. 2020 10 14; 94(21).
Score: 0.227
-
Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients. Nat Commun. 2020 08 26; 11(1):4253.
Score: 0.225
-
Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight. 2019 10 17; 4(20).
Score: 0.212
-
Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection. J Virol. 2017 06 15; 91(12).
Score: 0.179
-
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Sci Transl Med. 2016 Feb 17; 8(326):326ra21.
Score: 0.164
-
Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference. J Virol. 2015 Dec; 89(23):11820-33.
Score: 0.160
-
Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014 Aug; 58(8):4885-93.
Score: 0.146
-
The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. J Gen Virol. 2014 Apr; 95(Pt 4):874-882.
Score: 0.142
-
One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus. J Virol. 2017 Jan 15; 91(2).
Score: 0.044
-
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proc Natl Acad Sci U S A. 2015 Jul 14; 112(28):8738-43.
Score: 0.039
-
Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. Antimicrob Agents Chemother. 2014 Aug; 58(8):4894-8.
Score: 0.036